{"id":"W2402339939","doi":"","title":"State of Pharmaceutical Research and Development in Canada. Bioequivalence of Drug Products with Special Characteristics. Report of the February 13-14, 1998 Canadian Society for Pharmaceutical Sciences Symposium.","year":2000,"lang":"en","type":"other","venue":"PubMed","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Bioequivalence; Pharmaceutical sciences; Pharmaceutical drug; Drug; Medicine; Pharmacology; Pharmacokinetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001691526,0.0001896426,0.000505109,0.000166705,0.00009290647,0.000006657634,0.0003682833,0.0001594128,0.00009694123],"category_scores_gemma":[0.0001143509,0.0001222487,0.00004737832,0.0004020683,0.002316664,0.00001756512,0.00009921777,0.0004273993,2.784185e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001658438,"about_ca_system_score_gemma":0.00432609,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4543583,"about_ca_topic_score_gemma":0.822763,"domain_scores_codex":[0.9979507,0.0001902485,0.0005285412,0.0004481657,0.0001943161,0.0006880519],"domain_scores_gemma":[0.9991181,0.000241163,0.0002374155,0.0002147013,0.00009439778,0.00009422893],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002132948,0.001013158,0.1663273,0.005616709,0.002516111,0.0001354015,0.001289146,0.000001868596,0.009433093,0.0002165703,0.4554284,0.3558893],"study_design_scores_gemma":[0.001034899,0.00006267073,0.1079805,0.0002973549,0.0001148168,0.00006376101,0.0000752509,0.000003276287,0.1107608,0.00002207781,0.7792695,0.0003151041],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8423231,0.01905325,0.00002319332,0.02010904,0.006652027,0.01908679,0.008095746,0.00005313049,0.08460372],"genre_scores_gemma":[0.8866341,0.003365198,0.004350361,0.0006104578,0.0005601047,0.0008828267,0.0001445724,0.0002372808,0.1032152],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3684047,"threshold_uncertainty_score":0.8535845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07050487294175384,"score_gpt":0.3214421824816812,"score_spread":0.2509373095399274,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}